Artal Group S.A.
- SEC CIK
- 0001053906
- Latest filing
- Aug 13, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 11, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 144
- +4 vs. Q3 2021
- Portfolio value
- $3.40B
- −$663.6M (−16.3%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 71,178,364 | $280.4M | 8.2% | 00.0% | Unchanged | History |
| WWWW International, Inc. | COM | 14,818,300 | $239.0M | 7.0% | 00.0% | Unchanged | History |
| MRTXMirati Therapeutics, Inc. | COM | 1,400,000 | $205.4M | 6.0% | +200,000+16.7% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 675,000 | $182.9M | 5.4% | +25,000+3.8% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 500,000 | $175.1M | 5.1% | −77,308−13.4% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 650,000 | $110.2M | 3.2% | −50,000−7.1% | Reduced | History |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $108.3M | 3.2% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 1,800,000 | $105.3M | 3.1% | +350,000+24.1% | Added | History |
| SGENSeagen Inc. | COM | 500,000 | $77.3M | 2.3% | +125,000+33.3% | Added | History |
| MORFMorphic Holding, Inc. | COM | 1,585,049 | $75.1M | 2.2% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 6,000,000 | $69.3M | 2.0% | −696,955−10.4% | Reduced | History |
| Bellus Health Inc New07987C204 | COM NEW | 8,500,000 | $68.4M | 2.0% | +3,250,000+61.9% | Added | – |
| KYMRKymera Therapeutics, Inc. | COM | 1,000,000 | $63.5M | 1.9% | +600,000+150.0% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 2,450,000 | $60.9M | 1.8% | +500,000+25.6% | Added | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 850,000 | $52.7M | 1.5% | +250,000+41.7% | Added | History |
| ERASErasca, Inc. | COM | 3,172,221 | $49.4M | 1.5% | 00.0% | Unchanged | History |
| KRYSKrystal Biotech, Inc. | COM | 700,000 | $49.0M | 1.4% | +200,000+40.0% | Added | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 1,500,000 | $48.6M | 1.4% | −300,000−16.7% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 1,000,000 | $45.6M | 1.3% | −300,000−23.1% | Reduced | History |
| IGMSIGM Biosciences, Inc. | COM | 1,500,000 | $44.0M | 1.3% | +150,000+11.1% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 1,250,000 | $42.8M | 1.3% | −250,000−16.7% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 1,000,000 | $42.5M | 1.3% | 00.0% | Unchanged | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $40.3M | 1.2% | +25,000+3.0% | Added | History |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $39.4M | 1.2% | 00.0% | Unchanged | History |
| RUBYRubius Therapeutics, Inc. | COM | 3,701,580 | $35.8M | 1.1% | −454,045−10.9% | Reduced | History |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $32.5M | 1.0% | 00.0% | Unchanged | History |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $31.6M | 0.9% | 00.0% | Unchanged | History |
| KLRSKalaris Therapeutics, Inc. | COM | 2,323,371 | $30.1M | 0.9% | 00.0% | Unchanged | History |
| EVOEvotec SE | SPONSORED ADS | 1,149,425 | $27.3M | 0.8% | +1,149,425 | New | History |
| EQRXEQRx, Inc. | COM | 4,000,000 | $27.3M | 0.8% | +4,000,000 | New | History |
| DNLIDenali Therapeutics Inc. | COM | 600,000 | $26.8M | 0.8% | +100,000+20.0% | Added | History |
| GOSSGossamer Bio, Inc. | COM | 2,358,968 | $26.7M | 0.8% | 00.0% | Unchanged | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $25.8M | 0.8% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 544,047 | $25.3M | 0.7% | −450,000−45.3% | Reduced | History |
| REPLReplimune Group, Inc. | COM | 900,000 | $24.4M | 0.7% | 00.0% | Unchanged | History |
| SDGRSchrodinger, Inc. | COM | 700,000 | $24.4M | 0.7% | 00.0% | Unchanged | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,500,000 | $23.6M | 0.7% | 00.0% | Unchanged | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $23.6M | 0.7% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 750,000 | $23.0M | 0.7% | +350,000+87.5% | Added | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $22.9M | 0.7% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $21.0M | 0.6% | +225,000+17.1% | Added | History |
| AGENAgenus Inc | COM NEW | 6,500,000 | $20.9M | 0.6% | +1,000,000+18.2% | Added | History |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $19.9M | 0.6% | 00.0% | Unchanged | History |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 2,152,291 | $19.4M | 0.6% | +1,302,291+153.2% | Added | History |
| IMAImageneBio, Inc. | COM | 1,549,513 | $19.4M | 0.6% | 00.0% | Unchanged | History |
| NGNovagold Resources Inc | COM NEW | 2,600,000 | $17.8M | 0.5% | 00.0% | Unchanged | History |
| APTXAptinyx Inc. | COM | 6,116,493 | $16.3M | 0.5% | 00.0% | Unchanged | History |
| TGTXTG Therapeutics, Inc. | COM | 800,000 | $15.2M | 0.4% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $14.8M | 0.4% | +150,000+27.3% | Added | History |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $14.7M | 0.4% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,050,000 | $14.7M | 0.4% | 00.0% | Unchanged | History |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $14.3M | 0.4% | 00.0% | Unchanged | History |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 1,000,000 | $14.2M | 0.4% | 00.0% | Unchanged | History |
| ALBOAlbireo Pharma, Inc. | COM | 600,000 | $14.0M | 0.4% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 4,000,000 | $13.0M | 0.4% | 00.0% | Unchanged | History |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $13.0M | 0.4% | 00.0% | Unchanged | History |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $12.1M | 0.4% | 00.0% | Unchanged | History |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $11.9M | 0.4% | 00.0% | Unchanged | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 250,000 | $11.9M | 0.4% | −100,000−28.6% | Reduced | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 1,000,000 | $11.9M | 0.3% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $11.3M | 0.3% | 00.0% | Unchanged | – |
| Exscientia PLC30223G102 | ADS | 550,000 | $10.9M | 0.3% | +550,000 | New | – |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $10.7M | 0.3% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 3,000,000 | $9.78M | 0.3% | +1,000,000+50.0% | Added | History |
| GRTSGritstone bio, Inc. | COM | 750,000 | $9.64M | 0.3% | +750,000 | New | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $8.78M | 0.3% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $8.70M | 0.3% | 00.0% | Unchanged | History |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $8.56M | 0.3% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 593,030 | $8.21M | 0.2% | 00.0% | Unchanged | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $8.10M | 0.2% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 1,000,000 | $8.07M | 0.2% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $8.03M | 0.2% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 500,000 | $8.01M | 0.2% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 450,000 | $7.70M | 0.2% | 00.0% | Unchanged | History |
| HARPHarpoon Therapeutics, Inc. | COM | 1,000,000 | $7.55M | 0.2% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 1,200,000 | $7.46M | 0.2% | 00.0% | Unchanged | History |
| ZYMEZymeworks Inc. | COM | 450,000 | $7.38M | 0.2% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $7.33M | 0.2% | 00.0% | Unchanged | – |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $7.20M | 0.2% | +450,000 | New | History |
| IMCRImmunocore Holdings plc | ADS | 200,000 | $6.85M | 0.2% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 700,000 | $6.70M | 0.2% | 00.0% | Unchanged | History |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $6.48M | 0.2% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 550,000 | $6.39M | 0.2% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $6.24M | 0.2% | 00.0% | Unchanged | History |
| SANASana Biotechnology, Inc. | COM | 400,000 | $6.19M | 0.2% | 00.0% | Unchanged | History |
| CRISCuris Inc | COM NEW | 1,300,000 | $6.19M | 0.2% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 405,347 | $6.12M | 0.2% | 00.0% | Unchanged | History |
| EVLOEvelo Biosciences, Inc. | COM | 1,000,000 | $6.07M | 0.2% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $6.00M | 0.2% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 250,000 | $5.94M | 0.2% | +107,500+75.4% | Added | – |
| ORICOric Pharmaceuticals, Inc. | COM | 400,000 | $5.88M | 0.2% | 00.0% | Unchanged | History |
| NEXINexImmune, Inc. | COM | 1,200,000 | $5.53M | 0.2% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $5.42M | 0.2% | 00.0% | Unchanged | History |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $5.28M | 0.2% | 00.0% | Unchanged | History |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $5.25M | 0.2% | 00.0% | Unchanged | History |
| MIRMirion Technologies, Inc. | COM CL A | 500,000 | $5.24M | 0.2% | +500,000 | New | History |
| SYRESpyre Therapeutics, Inc. | COM | 1,045,000 | $4.96M | 0.1% | 00.0% | Unchanged | History |
| ACIUAC Immune SA | SHS | 1,000,000 | $4.95M | 0.1% | 00.0% | Unchanged | History |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $4.93M | 0.1% | 00.0% | Unchanged | – |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $4.78M | 0.1% | 00.0% | Unchanged | History |
Options (6)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q3 2021 (8)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| XLRNAcceleron Pharma Inc | COM | 1,000,000 | $172.1M | 4.2% | History |
| BABAAlibaba Group Holding Ltd | ADR | 100,000 | $14.8M | 0.4% | History |
| DRNADicerna Pharmaceuticals Inc | COM | 700,000 | $14.1M | 0.3% | History |
| BPMCBlueprint Medicines Corp | COM | 100,000 | $10.3M | 0.3% | History |
| OLPXOlaplex Holdings, Inc. | COM | 225,000 | $5.51M | 0.1% | History |
| AVTRAvantor, Inc. | COM | 50,000 | $2.04M | 0.1% | History |
| OPTUOptimum Communications, Inc. | CL A | 27,000 | $559.0K | <0.1% | History |
| EQTEQT Corp | Stock | 9,678 | $198.0K | <0.1% | History |